WHO ICTRP trial
Clinical study of Fuzheng Jiedu prescription on immune escape of diffuse large…
ITMCTR2024000828 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting
Key facts
| Trial ID | ITMCTR2024000828 |
|---|---|
| Public title | Clinical study of Fuzheng Jiedu prescription on immune escape of diffuse large B-cell lymphoma |
| Scientific title | Clinical study of Fuzheng Jiedu prescription on immune escape of diffuse large B-cell lymphoma |
| Primary sponsor | Shanghai tenth People's Hospital |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Others |
| Countries | China |
| Conditions | Diffuse large B-cell lymphoma |
| Interventions | Experimental group:Receive Fuzheng Jiedu prescription combined with standard treatment.;Control group:Receive only standard treatment. |
| Registration date | Dec 15, 2024 |
| Target size | Experimental group:170;Control group:170 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: